Lucid Diagnostics Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Lucid Diagnostics Inc. (LUCD) reported Increase (Decrease) in Prepaid Expense and Other Assets of $1.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-12
- Lucid Diagnostics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$52.00K, a 106.87% decline year-over-year.
- Lucid Diagnostics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $1.25M, a 574.05% increase year-over-year.
- Lucid Diagnostics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-06-30 was $757.00K.
- Lucid Diagnostics Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-03-31 was $185.00K.
- Lucid Diagnostics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $1.84M.
- Lucid Diagnostics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$1.16M.
- Lucid Diagnostics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2021 was $2.09M, a 90.86% increase from fiscal 2020.
- Lucid Diagnostics Inc. increase (decrease) in prepaid expense and other assets for fiscal 2020 was $1.09M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $1.20M 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | $1.25M 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | $1.84M 10-K · filed 2026-03-25 | |||
| 2025-06-30 | $757.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $942.00K 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | $185.00K 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | -$1.16M 10-K · filed 2026-03-25 | |||
| 2022-03-31 | -$168.00K 10-Q · filed 2022-05-16 | $965.46K derived: sum of 2 quarters · filed 2022-05-16 | ||
| 2021-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $2.09M 10-K · filed 2022-04-06 | ||
| 2021-09-30 | $954.54K 10-Q · filed 2021-11-23 | |||
| 2021-03-31 | -$104.00K 10-Q · filed 2022-05-16 | $110.63K derived: sum of 2 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $214.63K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $1.09M 10-K · filed 2022-04-06 | ||
| 2020-09-30 | $879.37K 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |